Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study – final study results

Autor: Makhema, Joseph, Shava, Emily, Izu, Alane, Gaolathe, Tendani, Kuate, Lesego, Walker, Adam, Carty, Lucy, Georgiou, Panayiotis, Kgathi, Coulson, Choga, Wonderful T., Sekoto, Tumalano, Seonyatseng, Ngozana, Mogashoa, Tuelo, Maphorisa, Comfort N., Mohammed, Terence, Ntalabgwe, Tshenolo, Frank, Tshepho T., Matlhaku, Boitumelo, Diphoko, Ame, Phindela, Thandie, Kaunda, Agripa, Kgari, Poloko, Kanyakula, Thomas, Palalani, Gape, Phakedi, Isabella, Mmalane, Mompati, Taylor, Sylvia, Moyo, Sikhulile

Publikováno v: In IJID Regions March 2024 10:35-43

Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study results.

Autor: Makhema J; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA., Shava E; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Izu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Innovation, National Research Foundation South African Research Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa., Gaolathe T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Faculty of Medicine, University of Botswana, Gaborone, Botswana., Kuate L; Department of Health Systems Management, Clinical Services, Ministry of Health Botswana, Gaborone, Botswana., Walker A; Medical Evidence, Vaccine and Immune Therapies, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK., Carty L; Medical and Payer Evidence Statistics, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK., Georgiou P; Late Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Kgathi C; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Choga WT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana., Sekoto T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Seonyatseng N; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Mogashoa T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Maphorisa CN; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Mohammed T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Ntalabgwe T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Frank TT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Matlhaku B; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Diphoko A; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Phindela T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Kaunda A; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Kgari P; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Kanyakula T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Palalani G; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Phakedi I; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Mmalane M; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Taylor S; Infection Evidence Strategy, Vaccine and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Moyo S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA.; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Publikováno v: IJID regions [IJID Reg] 2023 Nov 10; Vol. 10, pp. 35-43. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2024).